Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ValueZone Launches with an Exclusive Free Investment Plan to Enhance Access to AI-Powered Crypto Trading
-
OkayCoin Predicts Major BTC Staking Gains Following Trump Election Win
-
Lucas GC Limited Announces Status of US$6 Million Share Repurchase Program
-
Prestige Wealth Inc. Announces Acquisitions of InnoSphere Tech and Closing of Acquisition of Wealth AI
-
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
-
NAR Chief Economist Lawrence Yun Forecasts 9% Increase in Home Sales for 2025 and 13% for 2026, with Mortgage Rates Stabilizing Near 6%
-
OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2024
-
Associated Capital Reports Results for the Third Quarter 2024
-
Greenridge Exploration Grants Incentive Stock Options
-
Ascot Reports Third Quarter 2024 Results
-
Radius Recycling, Inc. Appoints Marc Hathhorn as Chief Operating Officer
-
Arhaus Opens Showroom in Corte Madera, California
-
Teva to Present at the Jefferies London Healthcare Conference
-
Planet 13 Announces Q3 2024 Financial Results
-
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
-
CNL Strategic Capital Announces Operating Results for Third Quarter 2024
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement
-
Grayscale Investments® Announces Intention to Effect Reverse Share Splits for Grayscale® Bitcoin Mini Trust ETF (Ticker: BTC) and Grayscale® Ethereum Mini Trust ETF (Ticker: ETH)
-
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Matthews International Announces Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
-
Notification of share transaction by Director of Millicom (Tigo) shares
-
New Providence Acquisition Corp. II Announces Intention to Liquidate
-
Tidal Financial Group Announces Reverse Stock Split for Defiance Daily Target 2X Short MSTR ETF (Ticker: SMST)
-
Grupo Aeroportuario del Pacifico Announces Payment Date for the Second and Last Installment of the Capital Stock Reduction Approved at the Extraordinary Shareholders’ Meeting
-
Triumph Financial to Present at the Stephens Annual Investment Conference on November 19, in Nashville, Tennessee
-
Foster Swift Files Appeal on Behalf of Over 70 Michigan Municipalities to Protect Local Control Over Renewable Energy Regulations
-
Codexis Announces New Employment Inducement Grants
-
FutureFuel Releases Third Quarter 2024 Results
-
Landsea Homes to Present at the 16th Annual Southwest IDEAS Investor Conference in Dallas, Texas on Thursday, November 21
-
Tidal Financial Group Announces Reverse Stock Split for Defiance Daily Target 2X Long SMCI ETF (Ticker: SMCX)
-
Adams Resources & Energy, Inc. to Release Third Quarter 2024 Earnings and Host Conference Call on November 13
-
PacBio to Present at Upcoming Investor Conferences
-
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
-
AI Transportation Acquisition Corp Announces Postponement of Adjourned Extraordinary General Meeting in Lieu of the 2024 Annual Meeting of Shareholders
-
Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
-
Aptose Reports Results for the Third Quarter 2024
-
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
-
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to December 10, 2024
-
Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event
-
Novo Nordisk A/S - share repurchase programme
-
Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme
-
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
-
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
-
Nokia Corporation: Repurchase of own shares on 08.11.2024
-
2nd Annual Celebrity Golf Tournament Tees Off to Stop Human Trafficking
-
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infi
